Want to see JP:219A full AI Analyst Report?

Heartseed, Inc. (219A) Price & Analysis

5 Followers

219A Stock Chart & Stats

¥1804.00

-¥95.00(-2.73%)

At close: Jan 08 4:00 PM EST

¥1804.00

-¥95.00(-2.73%)

Day’s Range― - ―

52-Week Range¥1,343.00 - ¥3,925.00

Previous CloseN/A

Volume1.41M

Average Volume (3M)738.74K

Market Cap

¥38.23B

Enterprise Value¥32.19K

Total Cash (Recent Filing)¥7.34B

Total Debt (Recent Filing)¥890.00K

Price to Earnings (P/E)37.2

Beta1.25

Next Earnings

Aug 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)25.93

Shares Outstanding22,893,400

10 Day Avg. Volume469,170

30 Day Avg. Volume738,736

Financial Highlights & Ratios

PEG Ratio-2.00

Price to Book (P/B)5.17

Price to Sales (P/S)12.93

P/FCF Ratio37.21

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-94.5

Revenue Forecast (FY)¥451.00M

Bulls Say, Bears Say

Bulls Say

Very Low Leverage / Conservative Balance SheetExtremely low debt and a large equity base provide durable financial flexibility, enabling sustained R&D, clinical programs, or opportunistic M&A without urgent refinancing. This reduces insolvency risk and supports multi‑period strategic investments even if revenues fluctuate.

FY2025 Operating Turnaround And Revenue InflectionA marked FY2025 shift to ~3.0B revenue with ~20% net margin and ~23% EBIT margin signals improved product/market traction and operational leverage. Sustained execution on this trajectory would convert prior R&D investments into recurring profits and strengthen long‑term viability.

Positive Operating And Free Cash Flow In FY2025FCF roughly matching net income indicates higher quality earnings and the ability to internally fund growth, reduce dilution, and build reserves. If sustained, this cash profile supports capex, commercialization, and lowers dependency on external capital over multiple years.

Bears Say

Multi‑year Prior Losses And Cash BurnA history of prolonged losses and funding reliance creates execution risk: one good year may not indicate permanence. Recurring losses earlier imply operational scale issues or market adoption lag, increasing the chance management must re‑raise capital if growth or margins slip.

Inconsistent Gross Profit ReportingInconsistent gross profit figures complicate trend analysis and margin forecasting, making it harder to assess true unit economics or product profitability. This impedes reliable long‑range planning and raises uncertainty for investors and partners evaluating sustainable margins.

Sustainability Risk Of FY2025 Cash PerformanceA single year of positive cash flow after several years of burn may reflect timing or one‑off factors. If revenue growth or margins falter, the company could revert to negative cash generation, necessitating external financing and diluting shareholders or constraining strategic initiatives.

Heartseed, Inc. News

Heartseed doses first patient in EMERALD trial of HS-005 for dilated cardiomyopathy

Heartseed, Inc. ( ($JP:219A) ) just unveiled an announcement. Heartseed Inc. has begun dosing patients in its domestic...

2M ago

219A

Heartseed Advances HS-001 Heart Failure Therapy Toward Japan Approval After Positive Trial Readout

Heartseed, Inc. ( ($JP:219A) ) has issued an update. Heartseed Inc. reported results from its Phase I/II LAPiS...

2M ago

219A

Heartseed Narrows Quarterly Loss but Projects Deeper Full-Year Deficit

Heartseed, Inc. ( ($JP:219A) ) has provided an announcement. Heartseed Inc. reported non-consolidated net sales of ¥465 million...

2M ago

219A

Heartseed launches post-delivery RSU plan to align board pay with shareholder value

Heartseed, Inc. ( ($JP:219A) ) has shared an announcement. Heartseed Inc. has approved the grant of post-delivery restricted...

3M ago

219A

Heartseed revamps governance with new executive officer system and board changes

Heartseed, Inc. ( ($JP:219A) ) has provided an update. Heartseed Inc. announced it will introduce an executive officer...

5M ago

219A

Heartseed Issues Cautionary Notice Alongside FY2025 Financial Results

Heartseed, Inc. ( ($JP:219A) ) has shared an announcement. Heartseed Inc. has released an informational document presenting its...

5M ago

219A

Heartseed Swings to Profit in 2025 but Signals Return to Loss on Higher 2026 Investment

Heartseed, Inc. ( ($JP:219A) ) has provided an update. Heartseed Inc. reported non-consolidated net sales of ¥3,026 million...

5M ago

219A

Heartseed Inc. Revises Financial Forecast with Positive Outlook

Heartseed, Inc. ( ($JP:219A) ) has provided an announcement. Heartseed Inc. announced a revision of its full-year financial...

8M ago

219A

Heartseed Inc. Reports Strong Financial Recovery

Heartseed, Inc. ( ($JP:219A) ) has issued an announcement. Heartseed Inc. reported significant financial improvement for the twelve...

8M ago

219A

Heartseed, Inc. Advances Cardiac Therapy Trial After Regulatory Approval

Heartseed, Inc. ( ($JP:219A) ) has shared an announcement. Heartseed, Inc. announced the completion of a 30-day review...

9M ago

219A

219A FAQ

What was Heartseed, Inc.’s price range in the past 12 months?

Heartseed, Inc. lowest stock price was ¥1343.00 and its highest was ¥3925.00 in the past 12 months.

What is Heartseed, Inc.’s market cap?

Heartseed, Inc.’s market cap is ¥38.23B.

When is Heartseed, Inc.’s upcoming earnings report date?

Heartseed, Inc.’s upcoming earnings report date is Aug 14, 2026 which is in 17 days.

How were Heartseed, Inc.’s earnings last quarter?

Currently, no data Available

Is Heartseed, Inc. overvalued?

According to Wall Street analysts Heartseed, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Heartseed, Inc. pay dividends?

Heartseed, Inc. does not currently pay dividends.

What is Heartseed, Inc.’s EPS estimate?

Heartseed, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Heartseed, Inc. have?

Heartseed, Inc. has 22,893,400 shares outstanding.

What happened to Heartseed, Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Heartseed, Inc.?

Currently, no hedge funds are holding shares in JP:219A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Heartseed, Inc.

Headquartered in Tokyo, Japan, Heartseed, Inc. was established on November 30, 2015, by Keiichi Fukuda, Takumi Akiyama, Toshiharu Furukawa, and Yutaro Kasai. The company specializes in the development and advancement of cardiac regenerative medicine.